|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.580 CAD | 0.00% |
|
+7.87% | -1.79% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | |||||||
Online Sales | - | - | - | 13.55M | 29.4M | ||
Total Assets | - | - | - | - | 8.15M | ||
Operating Income | - | - | - | 1.42M | 5.16M | ||
Other Operations | - | - | - | 109K | 38K | ||
Total Assets | - | - | - | - | 1.08M | ||
Operating Income | - | - | - | -5.22M | -6.4M | ||
Pharmaceuticals | 8K | 196K | 2.56M | - | - | ||
Total Assets | 4.33M | 12.58M | 6.98M | - | - | ||
Interest Expense | - | -13K | -2K | - | - | ||
Income Tax Expense | - | - | 1K | - | - | ||
CAPEX | - | -41K | -26K | - | - | ||
EBT | -9.95M | -10.09M | -3.89M | - | - | ||
Gross Profit | 3K | 121K | 2.11M | - | - | ||
D&A | 40K | 43K | 35K | - | - | ||
Operating Income | -4.72M | -7.48M | -6.27M | - | - | ||
Net Income | -9.95M | -10.05M | -3.76M | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
United States | - | 34K | 2.42M | 13.55M | 29.4M | ||
Rest of The World | - | 41K | 59K | 109K | 38K | ||
United Kingdom | - | - | 83K | - | - | ||
Poland | - | 60K | - | - | - | ||
France | - | 61K | - | - | - | ||
Israel | 8K | - | - | - | - | ||
D&A | 40K | - | - | - | - | ||
Total Assets | 4.33M | - | - | - | - | ||
Gross Profit | 3K | - | - | - | - | ||
Net Income | -9.95M | - | - | - | - | ||
EBT | -9.95M | - | - | - | - | ||
Operating Income | -4.72M | - | - | - | - | ||
Interest Expense | - | - | - | - | - | ||
D&A | - | - | - | - | - | ||
Total Assets | - | - | - | - | - | ||
CAPEX | - | - | - | - | - | ||
Net Income | - | - | - | - | - | ||
EBT | - | - | - | - | - | ||
Operating Income | - | - | - | - | - |
- Stock Market
- Equities
- INNO Stock
- Financials InnoCan Pharma Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
